Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cellsSCHUURHUIS, Danita H; LESTERHUIS, W. Joost; PUNT, Cornelis J. A et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 7, pp 1109-1115, issn 0340-7004, 7 p.Article

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma PatientsTEL, Jurjen; AARNTZEN, Erik H. J. G; WINKELS, Gregor et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 3, pp 1063-1075, issn 0008-5472, 13 p.Article

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cellsSCHREIBELT, Gerty; BENITEZ-RIBAS, Daniel; SCHUURHUIS, Danita et al.Blood. 2010, Vol 116, Num 4, pp 564-574, issn 0006-4971, 11 p.Article

Toll-like receptor expression and function in human dendritic cel subsets: implications for dendritic cell-based anti-cancer immunotherapySCHREIBELT, Gerty; TEL, Jurjen; SLIEPEN, Kwinten H. E. W. J et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 10, pp 1573-1582, issn 0340-7004, 10 p.Article

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α productionMEYER-WENTRUP, Friederike; BENITEZ-RIBAS, Daniel; TACKEN, Paul J et al.Blood. 2008, Vol 111, Num 8, pp 4245-4253, issn 0006-4971, 9 p.Article